These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 39190255)

  • 1. Clinical impact of airflow obstruction after allogeneic hematopoietic stem cell transplantation.
    Nakao S; Tsukamoto S; Takeda Y; Ohwada C; Ri C; Izumi S; Kamata Y; Matsui S; Shibamiya A; Ishii A; Takaishi K; Takahashi K; Shiko Y; Oshima-Hasegawa N; Muto T; Mimura N; Yokote K; Nakaseko C; Sakaida E
    Int J Hematol; 2024 Oct; 120(4):501-511. PubMed ID: 39190255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation.
    Au BK; Au MA; Chien JW
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1072-8. PubMed ID: 21126596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with bronchiolitis obliterans syndrome and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation.
    Gazourian L; Rogers AJ; Ibanga R; Weinhouse GL; Pinto-Plata V; Ritz J; Soiffer RJ; Antin JH; Washko GR; Baron RM; Ho VT
    Am J Hematol; 2014 Apr; 89(4):404-9. PubMed ID: 24375545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation.
    Rhee CK; Ha JH; Yoon JH; Cho BS; Min WS; Yoon HK; Lee JW
    Yonsei Med J; 2016 Mar; 57(2):365-72. PubMed ID: 26847288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-Onset Noninfectious Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation: Single-Center Experience.
    Işık Ö; Erol S; Cengiz Seval G; Gürün Kaya A; Toprak SK; Özdemir Kumbasar Ö
    Exp Clin Transplant; 2024 May; 22(5):373-380. PubMed ID: 38970280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation.
    Alkhunaizi M; Patel B; Bueno L; Bhan N; Ahmed T; Arain MH; Saliba R; Rondon G; Dickey BF; Bashoura L; Ost DE; Li L; Wang S; Shpall E; Champlin RE; Mehta R; Popat UR; Hosing C; Alousi AM; Sheshadri A
    Transplant Cell Ther; 2023 Mar; 29(3):204.e1-204.e7. PubMed ID: 36503180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease.
    Chien JW; Duncan S; Williams KM; Pavletic SZ
    Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S106-14. PubMed ID: 19896545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of Screening Spirometry for Early Diagnosis of Bronchiolitis Obliterans Syndrome in Children After Allogeneic Hematopoietic Stem Cell Transplantation.
    Yoon JS; Chun YH; Lee JW; Chung NG; Cho B
    J Pediatr Hematol Oncol; 2015 Nov; 37(8):e462-7. PubMed ID: 26334431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early outcomes of lung transplantation for bronchiolitis obliterans syndrome after allogeneic haematopoietic stem cell transplantation: a single-centre experience.
    Jung HS; Lee JG; Yu WS; Lee CY; Haam SJ; Paik HC
    Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):914-918. PubMed ID: 27481680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haploidentical donor stem cell transplantation had a lower incidence of bronchiolitis obliterans syndrome compared with HLA-matched sibling donor transplantation in patients with hematologic malignancies: Benefit from ATG?
    Weng G; Fan Z; Xue H; Huang F; Xu N; Jin H; Yu S; Ye Z; Fan J; Xuan L; Liu Q
    Front Immunol; 2022; 13():1036403. PubMed ID: 36389692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of bronchiolitis obliterans syndrome after haplo- hematopoietic stem cell transplantation].
    Zhuang J; Gu B; Ke P; Liu YJ; Wu XJ; Xue SL; Hu XH; He XF; Ma X; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2019 May; 40(5):404-410. PubMed ID: 31207706
    [No Abstract]   [Full Text] [Related]  

  • 12. CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome.
    Kuzmina Z; Krenn K; Petkov V; Körmöczi U; Weigl R; Rottal A; Kalhs P; Mitterbauer M; Ponhold L; Dekan G; Greinix HT; Pickl WF
    Blood; 2013 Mar; 121(10):1886-95. PubMed ID: 23303823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for bronchiolitis obliterans syndrome in allogeneic hematopoietic stem cell transplantation.
    Mo XD; Xu LP; Liu DH; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Wang FR; Wang JZ; Liu KY; Huang XJ
    Chin Med J (Engl); 2013 Jul; 126(13):2489-94. PubMed ID: 23823823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to explore preventive and novel therapies for bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.
    Sengsayadeth SM; Srivastava S; Jagasia M; Savani BN
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1479-87. PubMed ID: 22449611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive value of pulmonary function test before transplantation for chronic pulmonary graft-versus-host-disease after allogeneic hematopoietic stem cell transplantation.
    Yang L; Cheng J; Li F; Qian R; Zhang X; Jin S; He X; Xu T; Hu X; Ma X; Chen J; Zhu Y; Chen F
    BMC Pulm Med; 2022 Dec; 22(1):473. PubMed ID: 36510158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung Function Monitoring After Lung Transplantation and Allogeneic Hematopoietic Stem Cell Transplantation.
    Sheshadri A; Sacks NC; Healey BE; Raza S; Boerner G; Huang HJ
    Clin Ther; 2022 May; 44(5):755-765.e6. PubMed ID: 35513911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation.
    Chien JW; Martin PJ; Gooley TA; Flowers ME; Heckbert SR; Nichols WG; Clark JG
    Am J Respir Crit Care Med; 2003 Jul; 168(2):208-14. PubMed ID: 12649126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor lymphocyte infusion may reduce the incidence of bronchiolitis obliterans after allogeneic stem cell transplantation.
    Forslöw U; Mattsson J; Gustafsson T; Remberger M
    Biol Blood Marrow Transplant; 2011 Aug; 17(8):1214-21. PubMed ID: 21193056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NHANES III equations enhance early detection and mortality prediction of bronchiolitis obliterans syndrome after hematopoietic SCT.
    Williams KM; Hnatiuk O; Mitchell SA; Baird K; Gadalla SM; Steinberg SM; Shelhamer J; Carpenter A; Avila D; Taylor T; Grkovic L; Pulanic D; Comis LE; Blacklock-Schuver B; Gress RE; Pavletic SZ
    Bone Marrow Transplant; 2014 Apr; 49(4):561-6. PubMed ID: 24419526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inert Gas Washout in Bronchiolitis Obliterans Following Hematopoietic Cell Transplantation.
    Nyilas S; Baumeler L; Tamm M; Halter JP; Savic S; Korten I; Meyer A; Singer F; Passweg JR; Latzin P; Stolz D
    Chest; 2018 Jul; 154(1):157-168. PubMed ID: 29275133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.